Small- and medium-sized pharmaceutical firms to face bumpy road

Published: 2008-01-14 07:00:00

Updated: 2008-01-14 07:00:00

Influenced by the rapidly changing outer environments surrounding domestic pharmaceutical industry, such as free trade agreements, positive list system for pharmaceuticals and imminent introduction of advanced good manufacturing practice (GMP) standards, small- and medium-sized drug makers will l...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK